Therapeutic Vaccines Market Size and Share to Surpass USD 87 Billion by 2035 - Exclusive Report by Roots Analysis

LONDON, Jan. 9, 2024 /PRNewswire/ -- The global therapeutic vaccines market is estimated to be worth USD 2 billion in 2023 and is anticipated to reach USD 87 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 35% during the forecast period from 2023 to 2035. LONDON,Jan. 9, 2024/PRNewswire/ -- The global therapeutic vaccines market is estimated to be worthUSD 2 billionin 2023 and is anticipated to reachUSD 87 billionby 2035. It is expected to...

LONDON, Jan. 9, 2024 /PRNewswire/ -- The global therapeutic vaccines market is estimated to be worth USD 2 billion in 2023 and is anticipated to reach USD 87 billion by 2035. It is expected to grow at a compounded annual growth rate (CAGR) of 35% during the forecast period from 2023 to 2035.

The growth in the therapeutic vaccines market is likely to be the result of growing cases of infectious diseases across the globe. Therapeutic vaccines are a novel class of vaccines that have been designed for the treatment of patients suffering from infectious diseases. These vaccines induce immunity and help the immune system to recognize foreign particles, specifically virus particles that cause diseases. Though therapeutic vaccines are not efficacious like prophylactic vaccines, they demonstrate long-lasting responses, high safety profile, and specificity in targeting diseases. Owing to its significance, several pharmaceutical companies are conducting extensive research on therapeutic vaccines to develop advanced solutions to address a broad range of diseases. It is worth highlighting here that over 350 therapeutic vaccines are currently under development stages for various infectious, oncological, hematological, and neurological disorders. The ongoing research and active participation of pharmaceutical companies in developing therapeutic vaccines are expected to propel the market during the forecast period.

Download Free PDF Brochure:

https://www.rootsanalysis.com/reports/global-therapeutic-vaccines-market/request-sample.html

Therapeutic Vaccine Market Report Scope:

 

Key Report Takeaway

Therapeutic Vaccines Market Insight

Market Drivers

The therapeutic vaccine market is propelling due to the growing prevalence of infectious diseases such as dengue, influenza, malaria, tuberculosis, and HIV across the globe. The growing cases of diseases put pressure on pharmaceutical companies to develop advanced therapeutic vaccine formulations to treat patients. The therapeutic vaccines market is also driven by the expanding pipeline of therapeutic vaccine candidates in the clinical development stages. The rising interest of key players to explore more applications of therapeutic vaccines is driving the market during the forecast period.

Market Restrictions

Several market restraints that restrict the growth include the high development cost of therapeutic vaccines, which is limiting the growth of the market. Moreover, manipulating the immune system to achieve positive therapeutic outcomes is one of the significant challenges limiting the development of these vaccines. Complex regulatory compliance associated with the development and approval of therapeutic vaccines leads to delays in production, ultimately impacting the growth of the market.

Growth Factors

Despite the market restraints, the market has been driven by increasing investment activities by government bodies and industrial and non-industrial players for the development of therapeutic vaccines. Increasing awareness in the healthcare industry about the potential of therapeutic vaccines in treating diseases has led to a surge in demand for these vaccines. Collaboration between the key players for the advancement in therapeutic vaccine development is attributed to the growth of the market during the forecast period. 

Request sample Pages at:

https://www.rootsanalysis.com/reports/global-therapeutic-vaccines-market/request-sample.html

Recent Developments in the Therapeutic Vaccines Market

It is worth noting here that several therapeutic vaccine market players are currently undergoing collaborations to develop advanced vaccine formulations for the treatment of diseases. Some of the recent partnerships that have taken place between key market players include:

Therapeutic Vaccines Market Segments

Based on the type of vaccine, the therapeutic vaccines market is segmented into antigen vaccines, dendritic vaccines, DNA vaccines, and peptide vaccines.

Based on the type of method of vaccine composition, the therapeutic vaccines market is segmented into autologous vaccines, allogeneic vaccines and other methods.

Based on the type of therapy, the therapeutic vaccines market is segmented into monotherapy and combination therapy.

Based on the type of target disease indication, the therapeutic vaccines market is segmented into neurological disorder, oncological disorders, myeloid leukemia, glioblastoma, lung cancer, ewing sarcoma, HIV Infection, amyotrophic lateral sclerosis, hepatocellular carcinoma, tuberculosis, colorectal cancer, colon cancer, anal cancer and cervical cancer.

Based on the route of administration, the therapeutic vaccines market is segmented into intramuscular, subcutaneous, oral, intranasal, intrathecal, Intradermal, and others.

Based on key geographical regions, the therapeutic vaccines market is segmented into North America, Europe, and Asia-Pacific.

Key Companies Profiled

Examples of the key companies engaged in the therapeutic vaccines market (which have also been profiled in the market report; the complete list of the companies is also included in the full report) include:

Browse Complete Report @https://www.rootsanalysis.com/reports/global-therapeutic-vaccines-market.html

Don't Miss Out on Other Interesting Titles: 

Vaccines Market - The global vaccines market size is estimated to be worth $94 billion in 2030.

Thermostable Vaccines Market - The thermostable vaccines market is estimated to be worth $XX  billion in 2021 and is expected to grow at compounded annual growth rate (CAGR) of 40% during the forecast period from 2021 to 2035.

Dendritic Cell Cancer Vaccines Market - The global dendritic cell cancer vaccines market is expected to reach $3.2 billion by 2030, growing at an annualized rate of over 20.7%.

Cold Chain Logistics Market - The cold chain logistics market size is estimated to be worth $4 billion in 2021

Key Benefits of Buying this Report

About Roots Analysis

Roots Analysis is a global leader in the pharma/biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists, and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research/consulting services dedicated to serving our clients in the best possible way.

Contact Us
Gaurav Chaudhary
Roots Analysis
+1 (415) 800 3415
Email: gaurav.chaudhary@rootsanalysis.com
Web: https://www.rootsanalysis.com/
Blog: https://www.rootsanalysis.com/blog/
Press Release: https://www.rootsanalysis.com/press-releases.html
Follow Us: LinkedIn| Twitter

Logo - https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/therapeutic-vaccines-market-size-and-share-to-surpass-usd-87-billion-by-2035---exclusive-report-by-roots-analysis-302029782.html